Company Overview of Crucell N.V.
Crucell N.V. discovers, develops, manufactures, and markets vaccines, proteins, and antibodies against infectious diseases in paediatric, travel and endemic, and respiratory fields. The company offers liquid pentavalent vaccines, recombinant hepatitis B vaccines, aluminum-free hepatitis A vaccines, live attenuated typhoid fever vaccines, drinkable vaccines, and virosomal adjuvanted influenza vaccines, as well as vaccines for protection against measles and rubella in children, adolescents, and adults. Crucell N.V. also develops an anti-influenza antibody for neutralizing group 2 influenza A viruses; and licenses its technologies to the biopharmaceutical industry. The company serves customers ...
Leiden, 2333 CN
Founded in 1993
31 71 519 9100
31 71 519 9800
Key Executives for Crucell N.V.
Executive Vice President of Development
Senior Vice President of Research and Development at Protein Business Unit
Head of Regulatory Affairs department
Compensation as of Fiscal Year 2015.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries